Frequently asked questions about OkuStim® and retinitis pigmentosa
What exactly is TES? How does OkuStim® work? Who can benefit from the therapy? On this page, you will find answers to the most important questions about the therapy, the OkuStim® 2 device, and the condition retinitis pigmentosa.
Questions about retinitis pigmentosa
Clear answers on the causes, symptoms, progression, and diagnosis of RP.
Retinitis pigmentosa (RP) is a hereditary retinal disease in which the light-sensitive cells in the retina slowly degenerate. The disease usually progresses insidiously and eventually leads to severe visual impairment.
Through ophthalmological examinations such as visual field measurement, ERG (electroretinogram), OCT, or genetic tests. The diagnosis is made in specialized centers.
Not currently. However, there are therapeutic approaches, such as TES therapy, that can slow down the progression of the disease.
Questions about TES therapy
How transcorneal electrical stimulation works, who it is suitable for, and what is known about its benefits and safety.
TES stands for transcorneal electrical stimulation. Weak electrical impulses are used to stimulate retinal cells via the cornea to maintain their function.
Patients place a special electrode on their eye. The neurostimulator transmits electrical impulses for approximately 30 minutes. This is intended to positively influence cell metabolism.
Typically once a week for 30 minutes at home.
Yes. Studies show that the method is well-tolerated. Side effects are rare and usually harmless (e.g., dry eye sensation).
Questions about OkuStim® therapy
Home use, prescription, costs, and support—everything you need to know about the OkuStim® system at a glance.
The core is the headset, which integrates the actual neurostimulator as well as the electrode holders. Additionally, special electrodes are included.
After a prescription from an ophthalmologist, you can obtain the system from an authorized supplier.
Instruction is provided by medical professionals directly at the point of sale.
We have summarized the most important steps for you here.
Additionally, you can read all the details in the instructions for use.
TES therapy is currently not part of routine health insurance coverage. Reimbursement may be possible on a case-by-case basis upon application.
Yes, in our user portraits, affected individuals share their experiences with OkuStim®.
Patient Stories
In the Service Materials & Downloads section, we provide the instructions for use in various languages.
Insights into Therapy,Research & Company
Education & Career: Achieving Disadvantage Compensation
Fair conditions without special privileges: How to apply for adjustments and implement them practically.
EUTB®: Free Participation Counseling
Independent, individual, and accessible: EUTB® supports you – including with cost coverage applications for OkuStim® therapy.
Retroactive reimbursement of OkuStim® for RP
The LSG Lower Saxony-Bremen considers impending blindness in Retinitis pigmentosa (RP) to be an emergency-like situation and obliges a health insurance company to retroactively reimburse the OkuStim®…